Annual Accounts Receivable
$7.27 B
+$1.71 B+30.65%
31 December 2023
Summary:
Amgen annual accounts receivable is currently $7.27 billion, with the most recent change of +$1.71 billion (+30.65%) on 31 December 2023. During the last 3 years, it has risen by +$2.74 billion (+60.62%). AMGN annual accounts receivable is now at all-time high.AMGN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$7.32 B
+$383.00 M+5.52%
30 September 2024
Summary:
Amgen quarterly accounts receivable is currently $7.32 billion, with the most recent change of +$383.00 million (+5.52%) on 30 September 2024. Over the past year, it has increased by +$1.17 billion (+19.07%). AMGN quarterly accounts receivable is now at all-time high.AMGN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMGN Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.6% | +19.1% |
| 3 y3 years | +60.6% | +53.6% |
| 5 y5 years | +103.0% | +102.9% |
AMGN Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +60.6% | at high | +53.6% |
| 5 y | 5 years | at high | +103.0% | at high | +102.9% |
| alltime | all time | at high | +1767.4% | at high | +1838.3% |
Amgen Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.32 B(+5.5%) |
| June 2024 | - | $6.93 B(+2.3%) |
| Mar 2024 | - | $6.78 B(-6.8%) |
| Dec 2023 | $7.27 B(+30.6%) | $7.27 B(+18.3%) |
| Sept 2023 | - | $6.14 B(+5.4%) |
| June 2023 | - | $5.83 B(+1.6%) |
| Mar 2023 | - | $5.74 B(+3.1%) |
| Dec 2022 | $5.56 B(+13.6%) | $5.56 B(+4.4%) |
| Sept 2022 | - | $5.33 B(-0.0%) |
| June 2022 | - | $5.33 B(+4.9%) |
| Mar 2022 | - | $5.08 B(+3.7%) |
| Dec 2021 | $4.89 B(+8.2%) | $4.89 B(+2.7%) |
| Sept 2021 | - | $4.76 B(+6.4%) |
| June 2021 | - | $4.48 B(+1.3%) |
| Mar 2021 | - | $4.42 B(-2.3%) |
| Dec 2020 | $4.53 B(+11.5%) | $4.53 B(+10.5%) |
| Sept 2020 | - | $4.09 B(-23.7%) |
| June 2020 | - | $5.37 B(+7.1%) |
| Mar 2020 | - | $5.01 B(+23.5%) |
| Dec 2019 | $4.06 B(+13.3%) | $4.06 B(+12.5%) |
| Sept 2019 | - | $3.61 B(-5.1%) |
| June 2019 | - | $3.80 B(+0.8%) |
| Mar 2019 | - | $3.77 B(+5.3%) |
| Dec 2018 | $3.58 B(+10.6%) | $3.58 B(+4.0%) |
| Sept 2018 | - | $3.44 B(-1.8%) |
| June 2018 | - | $3.50 B(-3.6%) |
| Mar 2018 | - | $3.63 B(+12.2%) |
| Dec 2017 | $3.24 B(+2.3%) | $3.24 B(-4.9%) |
| Sept 2017 | - | $3.40 B(-4.4%) |
| June 2017 | - | $3.56 B(+9.6%) |
| Mar 2017 | - | $3.25 B(+2.6%) |
| Dec 2016 | $3.17 B(+5.7%) | $3.17 B(-0.7%) |
| Sept 2016 | - | $3.19 B(+3.5%) |
| June 2016 | - | $3.08 B(0.0%) |
| Mar 2016 | - | $3.08 B(+2.8%) |
| Dec 2015 | $3.00 B(+17.6%) | $3.00 B(+3.2%) |
| Sept 2015 | - | $2.90 B(+4.4%) |
| June 2015 | - | $2.78 B(+9.1%) |
| Mar 2015 | - | $2.55 B(+0.1%) |
| Dec 2014 | $2.55 B(-5.6%) | $2.55 B(+8.1%) |
| Sept 2014 | - | $2.35 B(-12.7%) |
| June 2014 | - | $2.70 B(+7.3%) |
| Mar 2014 | - | $2.51 B(-6.8%) |
| Dec 2013 | $2.70 B(+7.1%) | $2.70 B(+1.0%) |
| Sept 2013 | - | $2.67 B(-0.1%) |
| June 2013 | - | $2.67 B(+5.8%) |
| Mar 2013 | - | $2.53 B(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $2.52 B(-13.1%) | $2.52 B(-6.6%) |
| Sept 2012 | - | $2.70 B(-0.4%) |
| June 2012 | - | $2.71 B(-9.4%) |
| Mar 2012 | - | $2.99 B(+3.2%) |
| Dec 2011 | $2.90 B(+24.0%) | $2.90 B(+6.3%) |
| Sept 2011 | - | $2.73 B(+0.4%) |
| June 2011 | - | $2.71 B(+7.8%) |
| Mar 2011 | - | $2.52 B(+7.8%) |
| Dec 2010 | $2.33 B(+10.7%) | $2.33 B(+5.8%) |
| June 2010 | - | $2.21 B(-2.8%) |
| Mar 2010 | - | $2.27 B(+7.7%) |
| Dec 2009 | $2.11 B(+1.7%) | $2.11 B(-9.5%) |
| Sept 2009 | - | $2.33 B(+6.8%) |
| June 2009 | - | $2.18 B(+8.6%) |
| Mar 2009 | - | $2.01 B(-3.1%) |
| Dec 2008 | $2.07 B(-1.3%) | $2.07 B(-1.9%) |
| Sept 2008 | - | $2.11 B(-9.3%) |
| June 2008 | - | $2.33 B(+4.8%) |
| Mar 2008 | - | $2.22 B(+5.9%) |
| Dec 2007 | $2.10 B(-1.1%) | $2.10 B(-2.5%) |
| Sept 2007 | - | $2.15 B(-0.4%) |
| June 2007 | - | $2.16 B(+0.3%) |
| Mar 2007 | - | $2.16 B(+1.6%) |
| Dec 2006 | $2.12 B(+20.1%) | $2.12 B(0.0%) |
| Sept 2006 | - | $2.12 B(+5.3%) |
| June 2006 | - | $2.02 B(+12.5%) |
| Mar 2006 | - | $1.79 B(+1.4%) |
| Dec 2005 | $1.77 B(+21.1%) | $1.77 B(+6.3%) |
| Sept 2005 | - | $1.66 B(-2.5%) |
| June 2005 | - | $1.71 B(+7.8%) |
| Mar 2005 | - | $1.58 B(+8.4%) |
| Dec 2004 | $1.46 B(+44.9%) | $1.46 B(+3.4%) |
| Sept 2004 | - | $1.41 B(+10.3%) |
| June 2004 | - | $1.28 B(+7.2%) |
| Mar 2004 | - | $1.20 B(+18.6%) |
| Dec 2003 | $1.01 B(+34.0%) | $1.01 B(+0.7%) |
| Sept 2003 | - | $1.00 B(+4.2%) |
| June 2003 | - | $960.70 M(+13.7%) |
| Mar 2003 | - | $845.20 M(+12.4%) |
| Dec 2002 | $752.00 M(+51.2%) | $752.00 M(+20.9%) |
| Sept 2002 | - | $622.20 M(+12.4%) |
| June 2002 | - | $553.50 M(+5.4%) |
| Mar 2002 | - | $525.10 M(+5.6%) |
| Dec 2001 | $497.20 M(+27.7%) | $497.20 M(+3.3%) |
| Sept 2001 | - | $481.50 M(+27.5%) |
| June 2001 | - | $377.50 M(-12.6%) |
| Mar 2001 | - | $431.70 M(+10.9%) |
| Dec 2000 | $389.20 M | $389.20 M |
FAQ
- What is Amgen annual accounts receivable?
- What is the all time high annual accounts receivable for Amgen?
- What is Amgen annual accounts receivable year-on-year change?
- What is Amgen quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Amgen?
- What is Amgen quarterly accounts receivable year-on-year change?
What is Amgen annual accounts receivable?
The current annual accounts receivable of AMGN is $7.27 B
What is the all time high annual accounts receivable for Amgen?
Amgen all-time high annual accounts receivable is $7.27 B
What is Amgen annual accounts receivable year-on-year change?
Over the past year, AMGN annual accounts receivable has changed by +$1.71 B (+30.65%)
What is Amgen quarterly accounts receivable?
The current quarterly accounts receivable of AMGN is $7.32 B
What is the all time high quarterly accounts receivable for Amgen?
Amgen all-time high quarterly accounts receivable is $7.32 B
What is Amgen quarterly accounts receivable year-on-year change?
Over the past year, AMGN quarterly accounts receivable has changed by +$1.17 B (+19.07%)